Clinical Trial Update: ER Stress in NAFLD [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial investigating ER stress in obesity and nonalcoholic fatty liver disease sponsored by Vanderbilt University has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Obesity

Snippet

Sponsor: Vanderbilt University | Conditions: Obesity, NAFLD | EARLY_Phase 1 | Status: WITHDRAWN